If there is a clearly defined limit for loan against shares, it is only logical that there will shortly be something similar for IPO financing as well now that regulators are looking at this route of financing closely
Anmol Ganjoo of JM Financial likes Divis Laboratories and Torrent Pharma from the pharma space.